Cargando…
Bromelain‐based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long‐term outcomes
In 2012 the European Medicines Agency approved a pineapple stem‐derived Bromelain‐based debridement concentrate of proteolytic enzymes (NexoBrid®, MediWound Ltd, Yavne, Israel) for adult deep burns. Over 10 000 patients have been successfully treated with NexoBrid® globally, including in the US. The...
Autores principales: | Shoham, Yaron, Gasteratos, Konstantinos, Singer, Adam J., Krieger, Yuval, Silberstein, Eldad, Goverman, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681521/ https://www.ncbi.nlm.nih.gov/pubmed/37455553 http://dx.doi.org/10.1111/iwj.14308 |
Ejemplares similares
-
555 Pain Management During Bromelain-Based Enzymatic Debridement in a U.S. Adult Burn Center
por: Buta, Martin, et al.
Publicado: (2023) -
49 Bromelain Based Enzymatic Debridement of Pediatric Deep Burns: Top Line Results of a Multicenter RCT
por: Shoham, Yaron, et al.
Publicado: (2022) -
Bromelain-based enzymatic burn debridement: Spanish multidisciplinary consensus
por: Serracanta, Jordi, et al.
Publicado: (2022) -
622 Oral Ketamine Administration During Bromelain Based Enzymatic Debridement of Burn Injury
por: Halicki, Elizabeth, et al.
Publicado: (2022) -
Enzymatic Debridement of Deep Thermal Burns in the Russian Federation: First Experience
por: Alekseev, Andrey A., et al.
Publicado: (2023)